Experienced in Pseudobulbar Affect

Francoise Bouhour

Groupement Hospitalier Est, 
Lyon, FR 
Experienced in Pseudobulbar Affect
Groupement Hospitalier Est, 
Lyon, FR 
OverviewLocationsClinical Research

Overview

Francoise Bouhour practices in Lyon, France. Ms. Bouhour is rated as an Experienced expert by MediFind in the treatment of Pseudobulbar Affect. Her top areas of expertise are Pompe Disease, Primary Lateral Sclerosis, Chronic Demyelinizing Neuropathy with IgM Monoclonal, and Camptocormism.

Her clinical research consists of co-authoring 77 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 1 article in the study of Pseudobulbar Affect.

Gender
Female

Locations

Groupement Hospitalier Est, Lyon, 69677, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

A Multicenter, Interventional, Open-label Study to Monitor the Evolution of Motor Function in SMA Type II Adults Patients Treated With SPINRAZA®
A Multicenter, Interventional, Open-label Study to Monitor the Evolution of Motor Function in SMA Type II Adults Patients Treated With SPINRAZA®
Enrollment Status: Completed
Publish Date: September 20, 2024
Intervention Type: Other
Study Phase: Not Applicable
Follow-up of a Cohort of Patients With Myasthenic Syndrome and COVID-19 Infection: Consequences on the Severity of Myasthenic Syndrome and Reciprocal Impact of the Two Pathologies on Their Respective Treatments
Follow-up of a Cohort of Patients With Myasthenic Syndrome and COVID-19 Infection: Consequences on the Severity of Myasthenic Syndrome and Reciprocal Impact of the Two Pathologies on Their Respective Treatments
Enrollment Status: Completed
Publish Date: October 06, 2023
Characterization of Sensory Neuropathies Associated With Anti-FGFR3 Antibodies
Characterization of Sensory Neuropathies Associated With Anti-FGFR3 Antibodies
Enrollment Status: Completed
Publish Date: February 10, 2023
Intervention Type: Other
View 2 Less Clinical Trials

77 Total Publications

Serum Neurofilament Light Chain Correlates With Clinical Severity and Predicts Mortality in Anti-IgLON5 Disease.
Serum Neurofilament Light Chain Correlates With Clinical Severity and Predicts Mortality in Anti-IgLON5 Disease.
Journal: Neurology(R) neuroimmunology & neuroinflammation
Published: October 08, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Bouhour's expertise for a condition
ConditionClose
    View All 7 Advanced Conditions
    View All 30 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile